These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19302906)

  • 21. Revisions in the prescribing information for Epoetin alfa: implications for nephrology nurses and patients on dialysis.
    Hayslip D
    Nephrol Nurs J; 2008; 35(2):163-7. PubMed ID: 18472685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
    Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
    Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
    Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
    Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of pharmaceutical items available from drugstores in Phnom Penh, Cambodia.
    Yang D; Plianbangchang P; Visavarungroj N; Rujivipat S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):741-7. PubMed ID: 15689098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality and Batch-to-Batch Consistency of Original and Biosimilar Epoetin Products.
    Halim LA; Brinks V; Jiskoot W; Romeijn S; Haselberg R; Burns C; Wadhwa M; Schellekens H
    J Pharm Sci; 2016 Feb; 105(2):542-550. PubMed ID: 26869417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin.
    Gianoncelli A; Bonini SA; Bertuzzi M; Guarienti M; Vezzoli S; Kumar R; Delbarba A; Mastinu A; Sigala S; Spano P; Pani L; Pecorelli S; Memo M
    BioDrugs; 2015 Aug; 29(4):285-300. PubMed ID: 26334631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?
    Macdougall IC; Roche A; Rossert J; Casadevall N; Francois P; Kemeny DM
    Nephrol Dial Transplant; 2004 Nov; 19(11):2901-5. PubMed ID: 15496566
    [No Abstract]   [Full Text] [Related]  

  • 28. Strengthening of national capacity in implementation of antimalarial drug quality assurance in Thailand.
    Vijaykadga S; Cholpol S; Sitthimongkol S; Pawaphutanan A; Pinyoratanachot A; Rojanawatsirivet C; Kovithvattanapong R; Thimasarn K
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():5-10. PubMed ID: 17547041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deteriorated tuberculosis drugs and management system problems in lower southern Thailand.
    Rookkapan K; Chongsuvivatwong V; Kasiwong S; Pariyawatee S; Kasetcharoen Y; Pungrassami P
    Int J Tuberc Lung Dis; 2005 Jun; 9(6):654-60. PubMed ID: 15971393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy.
    Patel JA; Curtis EG; Phillips GL
    Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?
    Macdougall IC
    Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii18-21. PubMed ID: 16079325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies.
    Wang T; Hoag SW; Eng ML; Polli J; Pandit NS
    J Clin Pharm Ther; 2015 Feb; 40(1):68-75. PubMed ID: 25381836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TlpTLE: epotin and pure red-cell aplasia: what do we have?
    Massimo G; Daria M; Giorgina PB; Alberto J
    Med Sci Monit; 2003 Jul; 9(7):LE18. PubMed ID: 12956116
    [No Abstract]   [Full Text] [Related]  

  • 34. Pure red-cell aplasia "epidemic"--mystery completely revealed?
    Locatelli F; Del Vecchio L; Pozzoni P
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S303-7. PubMed ID: 17556324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition and identification of UV-absorbing leachables in EPREX pre-filled syringes: an unexpected occurrence at a formulation-component interface.
    Pang J; Blanc T; Brown J; Labrenz S; Villalobos A; Depaolis A; Gunturi S; Grossman S; Lisi P; Heavner GA
    PDA J Pharm Sci Technol; 2007; 61(6):423-32. PubMed ID: 18410043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes.
    Blossom D; Noble-Wang J; Su J; Pur S; Chemaly R; Shams A; Jensen B; Pascoe N; Gullion J; Casey E; Hayden M; Arduino M; Budnitz DS; Raad I; Trenholme G; Srinivasan A;
    Arch Intern Med; 2009 Oct; 169(18):1705-11. PubMed ID: 19822828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework.
    Jacob S; Nichols J; Macdougall IC; Qureshi Z; Chen B; Yang YT; Norris LB; Bennett CL
    Am J Ther; 2018; 25(6):e670-e674. PubMed ID: 30169374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoetin-induced pure red cell aplasia: diagnosis and treatment.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):585-8. PubMed ID: 18089975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.